Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$10.4M
12 notices · 227,229 sh
Oct 2025 to Oct 2026
Reported ·
$19.4M
38 sales · 0 buys
Oct 2025 to Sep 2026
The two figures cover different periods.
22 of 38 reported sales carry the 10b5-1 box. Together they are 0.35% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-01Katie Peng, Director$48,610
1,006 shplan 2026-03-20Form 4s on file end Sep 23144 ↗ 2026-07-06Mohammed Qatanani, CHIEF SCIENTIFIC OFFICER$639,975
11,704 shplan 2025-03-31Form 4s on file end Sep 23144 ↗ 2026-07-01Joshua Reed, Director$167,274
3,053 shplan 2026-03-21144 ↗ Form 4, 2026-07-06: sold 3,053 at $53.74
Form 4 ↗2026-07-01Jeffrey S. Flier, Director$167,274
3,053 shplan 2026-03-31144 ↗ Form 4, 2026-07-06: sold 3,053 at $53.88
Form 4 ↗2026-07-01Kristina Burow, Director$167,274
3,053 shplan 2026-03-31144 ↗ Form 4, 2026-07-06: sold 3,053 at $53.74
Form 4 ↗2026-07-01Michael Gilman, Director$139,385
2,544 shplan 2026-03-31144 ↗ Form 4, 2026-07-06: sold 2,544 at $53.87
Form 4 ↗2026-07-01Katie Peng, Director$298,386
5,446 shplan 2026-03-20144 ↗ Form 4, 2026-07-06: sold 5,446 at $53.87
Form 4 ↗2026-04-06Mohammed Qatanani, CHIEF SCIENTIFIC OFFICER$1,170,634
23,408 shplan 2025-03-31no Form 4 on file144 ↗ 2026-02-23Mohammed Qatanani, CHIEF SCIENTIFIC OFFICER$409,947
8,484 shplan 2025-03-31144 ↗ Form 4, 2026-02-25: sold 8,484 at $47.07
Form 4 ↗2026-01-22Mohammed Qatanani, CHIEF SCIENTIFIC OFFICER$686,053
14,898 shplan 2025-03-31144 ↗ Form 4, 2026-01-23: sold 14,898 at $46.71
Form 4 ↗2025-12-16Katie Peng, Director$45,511
1,006 shplan 2024-11-20144 ↗ Form 4, 2025-12-18: sold 1,006 at $44.09
Form 4 ↗2025-12-04Mohammed Qatanani, CHIEF SCIENTIFIC OFFICER$6,433,178
149,574 shplan 2025-03-31144 ↗ Form 4, 2025-12-05: sold 136,462 at $45.21
Form 4 ↗